Beta-sitosterol as a promising anticancer agent for chemoprevention and chemotherapy: mechanisms of action and future prospects

Haoyu Wang,Zhi Wang,Zihui Zhang,Jingchun Liu,Li Hong

DOI: https://doi.org/10.1016/j.advnut.2023.05.013

IF: 9.3

2023-05-01

Advances in Nutrition

Abstract:Cancer is one of the primary causes of death worldwide and its incidence continues to increase year by year. Despite significant advances in research, the search for effective and non-toxic preventive and therapeutic agents remains greatly important. Cancer is a multimodal disease, where various mechanisms play significant roles in its occurrence and progression. This highlights the need for multi-targeted approaches that are not only safe and inexpensive, but provide effective alternatives for current therapeutic regimens. Beta-sitosterol (SIT), the most abundant phytosterol found in various plant foods represents such an option. Preclinical evidence over the past few decades has overwhelmingly shown that SIT exhibits multiple anticancer activities against a wide range of cancers, including liver, cervical, colon, stomach, breast, lung, pancreatic, and prostate cancers, as well as leukemia, multiple myeloma, melanoma, and fibrosarcoma. In this article, we present the latest advances and perspectives on SIT - systematically summarizing its antitumor mechanisms of action into seven main sections and combining current challenges and prospects - for its use as a promising agent for cancer prevention and treatment. Specifically, SIT plays a role in cancer prevention and treatment mainly by enhancing apoptosis, inducing cell cycle arrest, bidirectionally regulating oxidative stress, improving metabolic reprogramming, inhibiting invasion and metastasis, modulating immunity and inflammation, and combating drug resistance. Although SIT holds such great promise, the poor aqueous solubility and bioavailability coupled with low targeting efficacy limit its therapeutic efficacy and clinical application. Further research on novel drug delivery systems may improve these deficiencies. Overall, through complex and pleiotropic mechanisms, SIT has good potential for tumor chemoprevention and chemotherapy. However, no clinical trials have yet proven this potential. This review provides theoretical basis and rationality for the further design and conduct of clinical trials to confirm the anticancer activity of SIT.

nutrition & dietetics